malignant lymphoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients with histologically-confirmed malignant lymphoma 2)Patients who received informed consent 3)Untreated patients 4)>=20 years old 5)Written informed consent form prior to participation in the study
Exclusion criteria
Exclusion criteria: 1)Ptients with consciousness disturbance 2)Patients with severe physical dysfunction 3)Patients with severe mental disorder 4)Patients with pacemaker 5)Patients with pregnancy 6)Patients who can not stand continuously for 90 seconds 7)Patients that attending doctors judge to be inappropriate to perform this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in body composition(Skeltal muscle mass, Body fat mass) | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival Progression free survival Early mortality Response rate Adverse event | — |
Countries
Japan
Contacts
Yokohama Municipal Citizen's Hospital Department of Hematology